ABIOMED, Inc. 

(Public, NASDAQ:ABMD)   Watch this stock   
Find more results for ABMD
Feb 4, 2010
Q3 2010 Abiomed, Earnings Conference Call - Webcast
Feb 4, 2010
Q3 2010 Abiomed, Earnings Release
Jan 13, 2010
Abiomed, at JPMorgan Healthcare Conference - Webcast
Dec 1, 2009
Abiomed, at Piper Jaffray Healthcare Conference
More events from AOL Finance »    

Key stats and ratios

Q4 (Dec '09) 2009
Net profit margin -20.02% -43.16%
Operating margin -21.68% -40.32%
EBITD margin - -35.26%
Return on average assets -13.91% -24.88%
Return on average equity -16.34% -30.15%
Employees 386 -

Address

22 Cherry Hill Drive
Danvers, MA 01923
United States - Map
+1-978-6461400 (Phone)
+1-978-7778411 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

ABIOMED, Inc. discussions

  View all discussions »

Description

Abiomed Inc. is a provider of medical devices in circulatory support that offers a continuum of care in heart recovery to heart failure patients. The Company’s products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. Its products can be used in a range of clinical settings, including by heart surgeons for patients in profound shock and by interventional cardiologists for patients who are in shock, pre-shock or in need of prophylactic support in the cardiac catheterization lab, or cath lab. Its circulatory care products are designed to provide hemodynamic support for acute patients from the cath lab to the surgery suite aimed towards heart recovery and sending the patient home with his or her native heart. The Company’s cardiac assist products provide circulatory support to acute heart failure patients across the continuum of care in heart recovery.

Officers and directors

Michael R. Minogue
Chairman of the Board, President, Chief Executive Officer
Age: 42
Bio & Compensation - Reuters
Robert L. Bowen
Chief Financial Officer, Vice President, Treasurer
Age: 59
Bio & Compensation - Reuters
David M. Weber
Chief Operating Officer
Age: 47
Bio & Compensation - Reuters
William J. Bolt
Senior Vice President - Engineering and Quality Assurance
Age: 57
Bio & Compensation - Reuters
Michael G. Howley
Vice President, General Manager - Global Sales and Marketing
Age: 45
Bio & Compensation - Reuters
Andrew Greenfield
Vice President - Healthcare Solutions
Age: 36
Bio & Compensation - Reuters
Dorothy E. Puhy
Lead Director
Age: 57
Bio & Compensation - Reuters
Desmond H. O'Connell Jr.
Director
Age: 73
Bio & Compensation - Reuters
Henri A. Termeer
Director
Age: 63
Bio & Compensation - Reuters
W. Gerald Austen M.D.
Director
Age: 79
Bio & Compensation - Reuters